Related Experiment Videos
[Lymph node dissection in patients with renal cell carcinoma].
T Ebert1, D Schnell, L Weissbach
1Urologische Belegabteilung, EuromedClinic, Fürth. ebert@euromed.de
Der Urologe. Ausg. A
|May 5, 2005
Summary
The benefit of extensive lymph node dissection for renal cell carcinoma remains unclear. Current evidence suggests only excising suspicious lymph nodes during nephrectomy is recommended.
Area of Science:
- Urology
- Oncology
- Surgical Pathology
Context:
- The role of lymph node dissection in renal cell carcinoma (RCC) management is a long-standing debate.
- Previous retrospective studies have not confirmed benefits of extended lymph node dissection.
- The primary prospective randomized study (EORTC 30881) results are still preliminary.
Purpose:
- To evaluate the diagnostic and therapeutic value of lymph node dissection in renal cell carcinoma.
- To provide evidence-based recommendations for lymph node management in RCC patients.
Summary:
- The necessity of lymph node dissection in renal cell carcinoma (RCC) has been debated for years.
- Retrospective analyses have failed to establish a clear diagnostic or therapeutic advantage for extended lymph node dissection.
- The sole prospective randomized trial (EORTC 30881) has yielded preliminary findings.
Impact:
- Current evidence does not support routine extended lymph node dissection in RCC.
- Recommendations focus on excising only lymph nodes identified as suspicious through imaging or palpation during nephrectomy.
- This approach aims to optimize patient outcomes while avoiding unnecessary surgical morbidity.